Journey Medical Corp
General ticker "DERM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $103.7M
Journey Medical Corp follows the US Stock Market performance with the rate: 32.7%.
Estimated limits based on current volatility of 2.9%: low 4.23$, high 4.49$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.69$, 8.66$]
- 2024-12-30 to 2025-12-30 estimated range: [3.13$, 7.47$]
Financial Metrics affecting the DERM estimates:
- Negative: Non-GAAP EPS, $ of -0.35 <= 0.10
- Negative: Operating profit margin, % of -2.55 <= 1.03
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: 2.35 < Operating cash flow per share per price, % of 4.65
Short-term DERM quotes
Long-term DERM plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $63.13MM | $73.67MM | $79.18MM |
Operating Expenses | $98.02MM | $101.19MM | $81.25MM |
Operating Income | $-34.88MM | $-27.52MM | $-2.07MM |
Non-Operating Income | $-7.48MM | $-2.05MM | $-1.56MM |
Interest Expense | $7.03MM | $2.02MM | $1.70MM |
R&D Expense | $16.56MM | $10.94MM | $7.54MM |
Income(Loss) | $-42.36MM | $-29.57MM | $-3.63MM |
Taxes | $1.63MM | $0.06MM | $0.22MM |
Profit(Loss) | $-43.99MM | $-29.63MM | $-3.85MM |
Stockholders Equity | $42.04MM | $16.98MM | $20.35MM |
Inventory | $9.86MM | $14.16MM | $10.21MM |
Assets | $97.28MM | $105.16MM | $76.85MM |
Operating Cash Flow | $-2.18MM | $-13.53MM | $5.24MM |
Capital expenditure | $10.00MM | $20.00MM | $5.00MM |
Investing Cash Flow | $-10.00MM | $-20.00MM | $-5.00MM |
Financing Cash Flow | $53.02MM | $16.46MM | $-4.80MM |
Earnings Per Share* | $-2.54 | $-1.69 | $-0.21 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.